On Demand 2016 Practice Management Package

Price: $208 members, $312 non-members

You can earn up to 13 AMA PRA Category 1 Credit(s)™. 

This collection covers sessions for Practice Management/Professional Issues. The sessions listed below are included in this package.

  • Practice Essentials: Practice Management Boot Camp
  • W8 - Advocacy Council 2016 Update on Coding: What You Need to Know
  • W10 - Gadgets & Gizmos
  • W16 - Advocacy Council: Update on Legal / Regulatory Issues (UPS, DASH, ICD-10, etc.)
  • W18 - Essentials of Sterile Compounding for the Allergy Practice
  • W19 - Surviving and Optimizing in the World of EHR
  • Bela Schick Lecture: "MOC”k-e-y Mouse - Is MOC Really “Mickey Mouse” for the Allergist?

Release Date: 12/01/2016
Expiration Date: 11/30/2019

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 13 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

  • Describe the proper coding for appropriate billing to optimize reimbursement
  • Discuss the new payment models and understand how other regulatory changes are impacting allergy practice
  • Interpret allergy-specific compensation and production data (RVUs)
  • Analyze allergists’ beliefs on fairness in compensation and career satisfaction
  • Critique allergists’ productivity in the workplace
  • Explain why the conversion to ICD-10 occurred and why correct coding is important
  • Identify and coordinate ICD-10 and CPT codes
  • Identify ICD-10 codes that were not used in the past, but that may be helpful in the future
  • Identify new ICD-10 codes that may be needed in the future
  • Explain why the RUC reviews codes and how its decisions can impact allergy
  • Adapt these new regulatory requirements to their practices
  • Explain why developing alternative payment models is important to allergists; and use Advocacy Council resources
  • Describe requirements of USP 797 and relevant guidelines for allergen extract compounding
  • Demonstrate the technique of sterile compounding required in office-based practice
  • Define best practices for implementing an EHR in the practice
  • Identify the root causes of common issues with EHRs in the practice
  • Recognize how ABAI truly functions as an organization
  • Learn the differences between ABAI and other ABMS boards
  • Learn potential benefits to practice by participating in MOC
Additional information
Disclosure: 

Stanley M. Fineman, MD, MBA, FACAAI -- Consultant/Advisor: Aimmune; Speaker: AstraZeneca, Boehringer Ingelheim, Genentech, Greer, Meda, Novartis, Nestle, Teva; Supported/Contracted Research: DBV Technologies, Genentech, Greer, Meda, Aimmune, Stallergenes

J. Allen Meadows, MD, FACAAI -- Speaker: Meda

James M. Tracy, DO, FACAAI -- Consultant/Advisor: Shire; Speaker: UptoDate

Michael S. Blaiss, MD, FACAAI -- Consultant/Advisor: Response Scientific, JDP Therapeutics, Pfizer; Ownership Interest: AllergyZone, Response Scientific, JDP Therapeutics

Gary Steven, MD, FACAAI -- Consultant/Advisor: AstraZeneca, Meda; Speaker: Aerocrine, AstraZeneca, Boehringer Ingelheim, Greer, Meda, Merck, Stallergenees; Supported/Contracted Research: AstraZeneca, Circassia, Genentech, GlaxoSmithKline, Merck, Mylan, Novartis, Roche, Teva

Mark L. Corbett, MD, FACAAI -- Consultant/Advisor: AstraZeneca, Merck; Speaker: AstraZeneca, Merck

The following have no financial relationships to disclose:

Gary N. Gross, MD, FACAAI

Bryan L. Martin, DO, FACAAI

Michael R. Nelson, MD, PhD, FACAAI

Gerald B. Lee, MD

Kay Tyler, BS, BA, MBA

This activity is supported by independent educational grants from the following commercial supporters:

AstraZeneca Partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Boston Scientific Supporter of the Virtual Roundtable on Advancing Management of Severe Asthma: A Review of Available Evidence to Guide Current Treatment.

CSL Behring Supporter of the Friday Symposium on Diagnosis and Treatment of Primary Immune Deficiency.

Dormer Laboratories Inc. In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

GlaxoSmithKline Supporter of the Sunday Symposium on What to Do When Asthma Does Not Respond to Step 3 Treatment…and partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Karl Storz Endoscopy-America, Inc. In-kind support consisting of loaned durable equipment for Workshops W12, W15 and W17 – Hands-On Session in Rhinolaryngoscopy.

Meda Pharmaceuticals, Inc. Supporter of the Monday Plenary Session on Asthma in 2016: Advances in Understanding Origin, Presentation and Approaches to Management.

Micro Direct, Inc. In-kind support consisting of loaned durable equipment for Workshops AHP3 and AHP6 Nuts and Bolts of Spirometry Interpretation.

Mylan Specialty L.P. Supporter of the Friday Breakfast Symposium on Leading the Pack: Allergists as Anaphylaxis Experts.

Nestlé Nutrition Institute Supporter of Workshop W11 on Food Allergies: What’s New in Prevention and Treatment.

Regeneron Pharmaceuticals/ Sanofi Genzyme Partial support of the Monday Plenary Session on Modern Therapies for Allergic Skin Diseases.

Salix Pharmaceuticals Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and a video session of the symposium.

Shire Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and the Sunday Symposium on Immunoglobulin Replacement for the Allergist: Update on Guidelines.

SmartPractice In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

Teva Respiratory Supporter of the Friday Symposium on The Use of Biologics in Severe Asthma.

Course summary
Available credit: 
  • 13.00 AMA PRA Category 1 Credit™
  • 13.00 Attendance
Course opens: 
12/01/2016
Course expires: 
11/30/2019
Cost:
$312.00
Rating: 
0

Available Credit

  • 13.00 AMA PRA Category 1 Credit™
  • 13.00 Attendance

Accreditation Period

Course opens: 
12/01/2016
Course expires: 
11/30/2019

Price

Cost:
$312.00
Please login or create an account to take this course.